Product Details for NDA 017503
COMBIPRES (CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE)
15MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
15MG;0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
15MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
15MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
Proprietary Name: COMBIPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017503
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
COMBIPRES (CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE)
Proprietary Name: COMBIPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG;0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017503
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
15MG;0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
Proprietary Name: COMBIPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG;0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017503
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
COMBIPRES (CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE)
Proprietary Name: COMBIPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG;0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017503
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
15MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: CHLORTHALIDONE; CLONIDINE HYDROCHLORIDE
Proprietary Name: COMBIPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017503
Product Number: 003
Approval Date: Apr 10, 1984
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: COMBIPRES
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 15MG;0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N017503
Product Number: 003
Approval Date: Apr 10, 1984
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status: Discontinued
Patent and Exclusivity Information